Please enable JavaScript to continue using this application.

Compare $ARMP vs $RNA | Chartloom

Compare

$ARMP vs $RNA

Armata Pharmaceuticals Inc · Atrium Therapeutics Inc

ARMP

Armata Pharmaceuticals Inc

RNA

Atrium Therapeutics Inc

Compare $ARMP vs $RNA

Comparing Armata Pharmaceuticals Inc and Atrium Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

RNAAtrium Therapeutics Inc

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

RNAAtrium Therapeutics Inc

Market cap

$144M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

22.0%

YTD performance

-88.3%

52W performance

-82.6%

FCF yield

-55.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

RNA

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

RNA

Atrium Therapeutics Inc

Market Cap

ARMP$133M

RNA$144M

Enterprise Value

ARMP$393M

RNA$71M

Price

ARMP$3.63

RNA$8.40

P/E Ratio

ARMPN/A

RNAN/A

P/S Ratio

ARMP24.04x

RNA3.48x

EV/Sales

ARMP70.87x

RNA1.73x

EV/EBITDA

ARMP0.00x

RNA0.00x

P/B Ratio

ARMP6.85x

RNA0.63x

P/FCF Ratio

ARMPN/A

RNAN/A

EV/FCF

ARMP-15.23x

RNA-0.89x

PEG Ratio

ARMPN/A

RNAN/A

Forward P/E (NTM)

ARMPN/A

RNAN/A

Forward P/S (NTM)

ARMPN/A

RNAN/A

Revenue (TTM)

ARMP$6M

RNA$41M

Revenue Growth (YoY)

ARMP-19.3%

RNA22.0%

Forward Rev Growth

ARMP-35.3%

RNA-94.2%

Gross Margin (TTM)

ARMP0.0%

RNA0.0%

Operating Margin (TTM)

ARMP0.0%

RNA0.0%

EBITDA Margin (TTM)

ARMP-603.4%

RNA-215.0%

Net Margin (TTM)

ARMP-3467.0%

RNA-209.2%

FCF Margin (TTM)

ARMP-465.3%

RNA-193.4%

Net Income (TTM)

ARMP$-192M

RNA$-86M

FCF (TTM)

ARMP$-26M

RNA$-80M

EPS (TTM)

ARMP-$3.10

RNA-$5.05

ROE (TTM)

ARMP-12000.0%

RNA-4030.0%

ROA (TTM)

ARMP-23569.0%

RNA-5864.0%

ROIC (TTM)

ARMP-8123.0%

RNA-4433.7%

Cash

ARMP$24M

RNA$72M

Debt

ARMP$284M

RNA$0

Net Cash/Debt

ARMP$-260M

RNA$72M

Current Ratio (TTM)

ARMP0.11x

RNA8.73x

Quick Ratio (TTM)

ARMP0.11x

RNA8.59x

Debt/Equity (TTM)

ARMP1.38x

RNA0.00x

Debt/Assets (TTM)

ARMP0.0%

RNA0.0%

Interest Coverage (TTM)

ARMPN/A

RNAN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

RNA0.00x

Beta

ARMP1.66

RNA1.20

52W Performance

ARMP12.7%

RNA-82.6%

YTD Performance

ARMP-44.7%

RNA-88.3%

% from 52W High

ARMP-77.8%

RNA-88.5%

% from 52W Low

ARMP17.5%

RNA10.1%

Asset Turnover (TTM)

ARMP0.07x

RNA0.28x

FCF Yield (TTM)

ARMP-19.4%

RNA-55.5%

Earnings Yield (TTM)

ARMP-144.2%

RNA-60.1%

Dividend Yield (TTM)

ARMPN/A

RNAN/A

Rule of 40

ARMP-484.6

RNA-171.3

EV/GP/RG

ARMPN/A

RNAN/A

Ticker research

View ARMP research View RNA research

Metric	ARMP Armata Pharmaceuticals Inc	RNA Atrium Therapeutics Inc
Market & Valuation
Market Cap	$133M	$144M
Enterprise Value	$393M	$71M
Price	$3.63	$8.40
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	3.48x
EV/Sales	70.87x	1.73x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	0.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$41M
Revenue Growth (YoY)	-19.3%	22.0%
Forward Rev Growth	-35.3%	-94.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-215.0%
Net Margin (TTM)	-3467.0%	-209.2%
FCF Margin (TTM)	-465.3%	-193.4%
Net Income (TTM)	$-192M	$-86M
FCF (TTM)	$-26M	$-80M
EPS (TTM)	-$3.10	-$5.05
ROE (TTM)	-12000.0%	-4030.0%
ROA (TTM)	-23569.0%	-5864.0%
ROIC (TTM)	-8123.0%	-4433.7%
Financial Health
Cash	$24M	$72M
Debt	$284M	$0
Net Cash/Debt	$-260M	$72M
Current Ratio (TTM)	0.11x	8.73x
Quick Ratio (TTM)	0.11x	8.59x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.20
52W Performance	12.7%	-82.6%
YTD Performance	-44.7%	-88.3%
% from 52W High	-77.8%	-88.5%
% from 52W Low	17.5%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.28x
FCF Yield (TTM)	-19.4%	-55.5%
Earnings Yield (TTM)	-144.2%	-60.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-171.3
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View RNA research

Valuation

P/S Ratio

RNA

3.48x

ARMP

24.04x

EV/FCF

ARMP

-15.23x

RNA

-0.89x

Growth & revenue

Revenue Growth TTM

RNA

22.0%

ARMP

-19.3%

Forward Revenue Growth

ARMP

-35.3%

RNA

-94.2%

Profitability & performance

Gross Margin

ARMP

0.0%

RNA

0.0%

ROE

RNA

-4030.0%

ARMP

-12000.0%

FCF Yield %

ARMP

-19.4%

RNA

-55.5%

52-Week Performance

ARMP

12.7%

RNA

-82.6%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

RNA

Atrium Therapeutics Inc

Market Cap

ARMP$133M

RNA$144M

Enterprise Value

ARMP$393M

RNA$71M

Price

ARMP$3.63

RNA$8.40

P/E Ratio

ARMPN/A

RNAN/A

P/S Ratio

ARMP24.04x

RNA3.48x

EV/Sales

ARMP70.87x

RNA1.73x

EV/EBITDA

ARMP0.00x

RNA0.00x

P/B Ratio

ARMP6.85x

RNA0.63x

P/FCF Ratio

ARMPN/A

RNAN/A

EV/FCF

ARMP-15.23x

RNA-0.89x

PEG Ratio

ARMPN/A

RNAN/A

Forward P/E (NTM)

ARMPN/A

RNAN/A

Forward P/S (NTM)

ARMPN/A

RNAN/A

Revenue (TTM)

ARMP$6M

RNA$41M

Revenue Growth (YoY)

ARMP-19.3%

RNA22.0%

Forward Rev Growth

ARMP-35.3%

RNA-94.2%

Gross Margin (TTM)

ARMP0.0%

RNA0.0%

Operating Margin (TTM)

ARMP0.0%

RNA0.0%

EBITDA Margin (TTM)

ARMP-603.4%

RNA-215.0%

Net Margin (TTM)

ARMP-3467.0%

RNA-209.2%

FCF Margin (TTM)

ARMP-465.3%

RNA-193.4%

Net Income (TTM)

ARMP$-192M

RNA$-86M

FCF (TTM)

ARMP$-26M

RNA$-80M

EPS (TTM)

ARMP-$3.10

RNA-$5.05

ROE (TTM)

ARMP-12000.0%

RNA-4030.0%

ROA (TTM)

ARMP-23569.0%

RNA-5864.0%

ROIC (TTM)

ARMP-8123.0%

RNA-4433.7%

Cash

ARMP$24M

RNA$72M

Debt

ARMP$284M

RNA$0

Net Cash/Debt

ARMP$-260M

RNA$72M

Current Ratio (TTM)

ARMP0.11x

RNA8.73x

Quick Ratio (TTM)

ARMP0.11x

RNA8.59x

Debt/Equity (TTM)

ARMP1.38x

RNA0.00x

Debt/Assets (TTM)

ARMP0.0%

RNA0.0%

Interest Coverage (TTM)

ARMPN/A

RNAN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

RNA0.00x

Beta

ARMP1.66

RNA1.20

52W Performance

ARMP12.7%

RNA-82.6%

YTD Performance

ARMP-44.7%

RNA-88.3%

% from 52W High

ARMP-77.8%

RNA-88.5%

% from 52W Low

ARMP17.5%

RNA10.1%

Asset Turnover (TTM)

ARMP0.07x

RNA0.28x

FCF Yield (TTM)

ARMP-19.4%

RNA-55.5%

Earnings Yield (TTM)

ARMP-144.2%

RNA-60.1%

Dividend Yield (TTM)

ARMPN/A

RNAN/A

Rule of 40

ARMP-484.6

RNA-171.3

EV/GP/RG

ARMPN/A

RNAN/A

Ticker research

View ARMP research View RNA research

Metric	ARMP Armata Pharmaceuticals Inc	RNA Atrium Therapeutics Inc
Market & Valuation
Market Cap	$133M	$144M
Enterprise Value	$393M	$71M
Price	$3.63	$8.40
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	3.48x
EV/Sales	70.87x	1.73x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	0.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$41M
Revenue Growth (YoY)	-19.3%	22.0%
Forward Rev Growth	-35.3%	-94.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-215.0%
Net Margin (TTM)	-3467.0%	-209.2%
FCF Margin (TTM)	-465.3%	-193.4%
Net Income (TTM)	$-192M	$-86M
FCF (TTM)	$-26M	$-80M
EPS (TTM)	-$3.10	-$5.05
ROE (TTM)	-12000.0%	-4030.0%
ROA (TTM)	-23569.0%	-5864.0%
ROIC (TTM)	-8123.0%	-4433.7%
Financial Health
Cash	$24M	$72M
Debt	$284M	$0
Net Cash/Debt	$-260M	$72M
Current Ratio (TTM)	0.11x	8.73x
Quick Ratio (TTM)	0.11x	8.59x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.20
52W Performance	12.7%	-82.6%
YTD Performance	-44.7%	-88.3%
% from 52W High	-77.8%	-88.5%
% from 52W Low	17.5%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.28x
FCF Yield (TTM)	-19.4%	-55.5%
Earnings Yield (TTM)	-144.2%	-60.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-171.3
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View RNA research